Search results for: “0 5”

Most recent guideline publication: The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for SLCO1B1, ABCG2, and CYP2C9 and statin-associated musculoskeletal symptoms (January 2022) Updates since publication: none Tables provided in the main manuscript of the guideline: Table 1. Assignment of predicted SLCO1B1, ABCG2, and CYP2C9 likely phenotype based on genotype Table 2. Dosing recommendations for statins…

Guideline overview presentation Most recent guideline publication: Expanded Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Medication Use in the Context of G6PD Genotype (August 2022) Tables  provided in the main manuscript of the guideline: Table 1. Assignment of predicted G6PD phenotype based on genotype Table 2. Drug-specific risk level and associated strength of recommendation for…

ClinPGx 2024: Knowledge, Implementation, Education MeetingJune 20th and 21st, 2024 in Philadelphia, PA More information What is CPIC? The Clinical Pharmacogenetics Implementation Consortium (CPIC®) is an international consortium of individual volunteers and a small dedicated staff who are interested in facilitating use of pharmacogenetic tests for patient care. One barrier to implementation of pharmacogenetic testing in…

There are a few different ways to stay in touch with CPIC. I have a question or comments Contact us with any questions or comments. I have a question or comment about allele function or diplotype-phenotype tables Contact us with questions specifically about CPIC alleles I want to get announcements CPIC has a public announcement…

Kelly E. Caudle, PharmD, PhD, BCPS, FCCP CPIC Co-PI/Director, Department of Pharmaceutical Sciences, St. Jude Children’s Research Hospital, Memphis, TN Dr. Caudle received her Pharm.D. and Ph.D. from The University of Tennessee Health Science Center and completed an ASHP-accredited PGY2 residency at Le Bonheur Children’s Hospital in Memphis, TN. She is also a board‐certified Pharmacotherapy…

January 2021 February 2021 Member survey results March 2021 Relling slides April 2021 Huddart slides May 2021 Caudle slides June 2021 July 2021 September 2021 Pratt slides Roden slides October 2021 Whirl-Carrillo slides (PharmCAT) November 2021 Relling slides December 2021 McLeod and Swen slides

Most recent guideline publication: Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for MT-RNR1 and Aminoglycosides (May 2021) Updates since publication: March 2023: This update to the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for the use of aminoglycosides in individuals with the MT-RNR1 genotype was precipitated following contact from primary care physicians and pediatricians. These clinicians had asked…

Working group documents/information (posted as needed): Link to sign-up to be a clinical champion: https://forms.gle/SRQBQjApyCDrxKEv8 Working group minutes:  2021 January 2020 May June September November  

CPIC guideline for thiopurines based on TPMT and NUDT15 gentoype   For gene-specific information tables (i.e. TPMT allele definition, allele functionality, frequency and diplotype-phenotype tables) see guideline pages or PharmGKB.

February 2020 Meeting slides March 2020 May 2020 Pratt slides June 2020 July 2020 Gaedigk slides July 2020 August 2020 September 2020 Thomas slides Whirl-Carrillo slides October 2020 Grillo and Schuck slides November 2020 Monte slides Empey slides December 2020 Bishop and Mueller slides